Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)
| קרן | National Cancer Institute/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 28/09/2018 |
| פקולטה | Engineering, Exact Sciences, Life Sciences, Medicine |
| תיאור | This grant solicits applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous validation to encourage adoption by the research community.
Funding: $300,000 per year Duration: 3 years
Research Authority due date: 10 days prior to submission LOI (encouraged) due date: 28.1.18, 29.4.18,28.8.18 Full proposal due date: 28.2.18, 29.5.18, 28.9.18 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 21/11/2017 |
